171 related articles for article (PubMed ID: 32111734)
1. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R
J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
Prasad S; Neef T; Xu D; Podojil JR; Getts DR; Shea LD; Miller SD
J Autoimmun; 2018 May; 89():112-124. PubMed ID: 29258717
[TBL] [Abstract][Full Text] [Related]
3. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.
Ryu S; Kodama S; Ryu K; Schoenfeld DA; Faustman DL
J Clin Invest; 2001 Jul; 108(1):63-72. PubMed ID: 11435458
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens.
Kleffel S; Vergani A; Tezza S; Ben Nasr M; Niewczas MA; Wong S; Bassi R; D'Addio F; Schatton T; Abdi R; Atkinson M; Sayegh MH; Wen L; Wasserfall CH; O'Connor KC; Fiorina P
Diabetes; 2015 Jan; 64(1):158-71. PubMed ID: 25187361
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
Li L; Yi Z; Wang B; Tisch R
J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
[TBL] [Abstract][Full Text] [Related]
6. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
Vazquez-Mateo C; Collins J; Goldberg SJ; Lawson M; Hernandez-Escalante J; Dooms H
PLoS One; 2019; 14(3):e0214379. PubMed ID: 30908554
[TBL] [Abstract][Full Text] [Related]
7. Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice.
Chen D; Kakabadse D; Fishman S; Weinstein-Marom H; Davies J; Boldison J; Thayer TC; Wen L; Gross G; Wong FS
Front Immunol; 2023; 14():1227133. PubMed ID: 37731505
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.
Stocks BT; Wilson CS; Marshall AF; Hoopes EM; Moore DJ
J Immunol; 2019 Jul; 203(1):158-166. PubMed ID: 31127035
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.
Bluestone JA; Tang Q
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14622-6. PubMed ID: 15322272
[TBL] [Abstract][Full Text] [Related]
10. Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery.
Hotta-Iwamura C; Benck C; Coley WD; Liu Y; Zhao Y; Quiel JA; Tarbell KV
J Autoimmun; 2018 Jun; 90():39-48. PubMed ID: 29439835
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with single chain antigen receptors for islet-derived peptides presented on I-A(g7) delays diabetes in NOD mice by inducing anergy in self-reactiveT-cells.
Gurr W; Shaw M; Herzog RI; Li Y; Sherwin R
PLoS One; 2013; 8(7):e69464. PubMed ID: 23894487
[TBL] [Abstract][Full Text] [Related]
12. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse.
Unanue ER; Ferris ST; Carrero JA
Immunol Rev; 2016 Jul; 272(1):183-201. PubMed ID: 27319351
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
Samanta D; Mukherjee G; Ramagopal UA; Chaparro RJ; Nathenson SG; DiLorenzo TP; Almo SC
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13682-7. PubMed ID: 21825122
[TBL] [Abstract][Full Text] [Related]
14. An Insulin-Inspired Supramolecular Hydrogel for Prevention of Type 1 Diabetes.
Liu M; Wang Z; Feng D; Shang Y; Li X; Liu J; Li C; Yang Z
Adv Sci (Weinh); 2021 May; 8(10):2003599. PubMed ID: 34026440
[TBL] [Abstract][Full Text] [Related]
15. Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
Garcia-Loza I; Perna-Barrull D; Aguilera E; Almenara-Fuentes L; Gomez-Muñoz L; Greco D; Vila M; Salvado M; Mancera-Arteu M; Olszowy MW; Petriz J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
J Autoimmun; 2024 May; 145():103196. PubMed ID: 38458075
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin gene-related peptide is a potential autoantigen for CD4 T cells in type 1 diabetes.
Li W; Li R; Wang Y; Zhang Y; Tomar MS; Dai S
Front Immunol; 2022; 13():951281. PubMed ID: 36189304
[TBL] [Abstract][Full Text] [Related]
17. Imaging the emergence and natural progression of spontaneous autoimmune diabetes.
Mohan JF; Kohler RH; Hill JA; Weissleder R; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7776-E7785. PubMed ID: 28839093
[TBL] [Abstract][Full Text] [Related]
18. Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
Verbeke CS; Gordo S; Schubert DA; Lewin SA; Desai RM; Dobbins J; Wucherpfennig KW; Mooney DJ
Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28116870
[TBL] [Abstract][Full Text] [Related]
19. Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.
Haque M; Das JK; Xiong X; Song J
Curr Diab Rep; 2019 Aug; 19(10):89. PubMed ID: 31471667
[TBL] [Abstract][Full Text] [Related]
20. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.
Haskins K; Cooke A
Curr Opin Immunol; 2011 Dec; 23(6):739-45. PubMed ID: 21917439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
